Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents

Attention Deficit ◽

Efficacy And Safety ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

CNS Drugs ◽

10.1007/s40263-013-0104-8 ◽

2013 ◽

Vol 27 (12) ◽

pp. 1081-1092 ◽

Cited By ~ 53

Author(s):

Ralf W. Dittmann ◽

Esther Cardo ◽

Peter Nagy ◽

Colleen S. Anderson ◽

Ralph Bloomfield ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Double Blind ◽

Hyperactivity Disorder ◽

Phase Iiib

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2011.01.007 ◽

2011 ◽

Vol 50 (4) ◽

pp. 395-405 ◽

Cited By ~ 72

Author(s):

Robert L. Findling ◽

Ann C. Childress ◽

Andrew J. Cutler ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate [LDX; NRP104] in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/00004703-200610000-00057 ◽

2006 ◽

Vol 27 (5) ◽

pp. 443 ◽

Cited By ~ 2

Author(s):

Joseph Biederman ◽

Hilary Mandler ◽

Suma Krishnan ◽

Robert L. Findling

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

CNS Drugs ◽

10.1007/s40263-017-0487-z ◽

2018 ◽

Vol 32 (1) ◽

pp. 85-95 ◽

Cited By ~ 7

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Caleb Bliss ◽

Brigitte Robertson ◽

Alessandro Zuddas

Keyword(s):

Cognitive Function ◽

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

958 – Efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: effect of age, sex and baseline disease severity

European Psychiatry ◽

10.1016/s0924-9338(13)76104-2 ◽

2013 ◽

Vol 28 ◽

pp. 1 ◽

Cited By ~ 1

Author(s):

M. Lecendreux ◽

T. Banaschewski ◽

C. Soutullo ◽

M. Johnson ◽

A. Zuddas ◽

...

Keyword(s):

Disease Severity ◽

Attention Deficit ◽

Hyperactivity Disorder ◽

Disorder Effect ◽

Effect Of Age ◽

Baseline Disease Severity

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-018-0514-8 ◽

2018 ◽

Vol 32 (5) ◽

pp. 455-467 ◽

Cited By ~ 6

Author(s):

Tobias Banaschewski ◽

Mats Johnson ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César A. Soutullo ◽

...

Keyword(s):

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial

European Child & Adolescent Psychiatry ◽

10.1007/s00787-013-0421-y ◽

2013 ◽

Vol 23 (2) ◽

pp. 61-68 ◽

Cited By ~ 20

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Michel Lecendreux ◽

Alessandro Zuddas ◽

Ralf W. Dittmann ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Attention Deficit ◽

Controlled Trial ◽

Hyperactivity Disorder ◽

Randomized Controlled

P.7.d.013 Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(15)30919-6 ◽

2015 ◽

Vol 25 ◽

pp. S648

Author(s):

A. Zuddas ◽

T. Banaschewski ◽

P. Nagy ◽

C. Soutullo ◽

B. Yan ◽

...

Keyword(s):

Attention Deficit ◽

Safety And Efficacy ◽

Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2013.11.005 ◽

2014 ◽

Vol 53 (2) ◽

pp. 174-187 ◽

Cited By ~ 75

Author(s):

Shimon Schwartz ◽

Christoph U. Correll

Keyword(s):

Attention Deficit ◽

Meta Analysis ◽

Efficacy And Safety ◽

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Behavioral and Brain Functions ◽

10.1186/1744-9081-6-34 ◽

2010 ◽

Vol 6 (1) ◽

pp. 34 ◽

Cited By ~ 86

Author(s):

Timothy Wigal ◽

Matthew Brams ◽

Maria Gasior ◽

Joseph Gao ◽

Liza Squires ◽

...

Keyword(s):

Crossover Study ◽

Attention Deficit ◽

Environment Design ◽

Efficacy And Safety ◽

Double Blind ◽

Workplace Environment ◽

Double Blind Placebo ◽